SCHEMBL6571583

SCHEMBL6571583

COc1cc(C(=O)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(Cc2ccccc2)C(CCc2ccncc2)CCc2ccncc2)cc(OC)c1OC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 4/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
G6PD P11413 1/20 0.37
FKBP1A P62942 3/20 0.36
LPAR1 Q92633 3/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
SLC2A1 P11166 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6571615 0.92 F10 (0.35) KMT2AL3MBTL1LMNASMN1; SMN2TDP1
SCHEMBL6573934 0.92 L3MBTL1 (0.40) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL6573929 0.92 L3MBTL1 (0.40) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
Timcodar SCHEMBL1492143 0.88 L3MBTL1 (0.37) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
Timcodar SCHEMBL3673444 0.88 L3MBTL1 (0.37) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL6572534 0.88 SLC2A4 (0.39) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL6570451 0.88 L3MBTL1 (0.37) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL6570385 0.88 SLC2A4 (0.39) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL6570448 0.88 L3MBTL1 (0.37) KMT2AL3MBTL1MAPK1ALDH1A1LMNA
SCHEMBL7177878 0.87 FKBP1A (0.40) KMT2AL3MBTL1MAPK1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840736-A PEPTIDES FOR NERVE GROWTH VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-11-24 US claimed
EP-0797567-B1 NOVEL AMINO ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMA (US) 2004-02-11 EP disclosed
EP-0946190-B1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE OUTGROWTH VERTEX PHARMA (US) 2003-09-24 EP disclosed
US-6284778-B1 NEUROTROPHIC AGENT VERTEX PHARMACEUTICALS INCORPORATED 2001-09-04 US disclosed
US-6172086-B1 TREATING PARKINSON*S DISEASE, ALZHIEMER*S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS AND OTHER NERVOUS SYSTEM DISORDERS VERTEX PHARMACEUTICALS INCORPORATED 2001-01-09 US disclosed
US-5840736-A PEPTIDES FOR NERVE GROWTH VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-11-24 US disclosed